organization · Reporting owner
HCFP/Capital Partners III LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PAVmed Inc.PAVM · Entity 7317 | 10% owner | April 05, 2018 | April 09, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PAVmed Inc.
Report date April 05, 2018 · Filed April 09, 2018
Jointly reported with Aklog Lishan, Pavilion Venture Partners LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $5.00 · Expires 2022-01-29 | Direct | 0 |
Reported balance
After 2018-04-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-04-05 · Disposition to issuer · Disposed 50,450 · Balance 0 F1: The reporting person disposed of the Warrants in exchange for Series Z Warrants in an issuer exchange offer. |
| Series Z WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $3.00 · Expires 2024-04-30 | Direct | 25,225 |
Reported balance
After 2018-04-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-04-05 · Grant · Acquired 25,225 · Balance 25,225 F1: The reporting person disposed of the Warrants in exchange for Series Z Warrants in an issuer exchange offer. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $5.00 · Expires 2022-01-29 | IndirectBy HCFP/Capital Partners III LLC | 0 |
Reported balance
After 2018-04-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-04-05 · Disposition to issuer · Disposed 5,646,562 · Balance 0 F1: The reporting person disposed of the Warrants in exchange for Series Z Warrants in an issuer exchange offer. F2: Dr. Aklog is a member and a co-manager of HCFP/Capital Partners III LLC, and shares joint voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his proportionate pecuniary interest therein. |
| Series Z WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $3.00 · Expires 2024-04-30 | IndirectBy HCFP/Capital Partners III LLC | 2,823,281 |
Reported balance
After 2018-04-05 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-04-05 · Grant · Acquired 2,823,281 · Balance 2,823,281 F1: The reporting person disposed of the Warrants in exchange for Series Z Warrants in an issuer exchange offer. F2: Dr. Aklog is a member and a co-manager of HCFP/Capital Partners III LLC, and shares joint voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his proportionate pecuniary interest therein. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $5.00 · Expires 2022-01-29 | IndirectBy Pavilion Venture Partners LLC | 0 |
Reported balance
After 2018-04-05 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-04-05 · Disposition to issuer · Disposed 2,220,532 · Balance 0 F1: The reporting person disposed of the Warrants in exchange for Series Z Warrants in an issuer exchange offer. F3: Dr. Aklog is a member and sole manager of Pavilion Venture Partners LLC, and has sole voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his proportionate pecuniary interest therein. |
| Series Z WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $3.00 · Expires 2024-04-30 | IndirectBy Pavilion Venture Partners LLC | 1,110,266 |
Reported balance
After 2018-04-05 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-04-05 · Grant · Acquired 1,110,266 · Balance 1,110,266 F1: The reporting person disposed of the Warrants in exchange for Series Z Warrants in an issuer exchange offer. F3: Dr. Aklog is a member and sole manager of Pavilion Venture Partners LLC, and has sole voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his proportionate pecuniary interest therein. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $5.00 · Expires 2022-01-29 | IndirectBy HCFP/AG LLC | 0 |
Reported balance
After 2018-04-05 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-04-05 · Disposition to issuer · Disposed 20,000 · Balance 0 F1: The reporting person disposed of the Warrants in exchange for Series Z Warrants in an issuer exchange offer. F4: Dr. Aklog is a co-manager of HCFP/AG LLC, and shares joint voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his pecuniary interest therein. |
| Series Z WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $3.00 · Expires 2024-04-30 | IndirectBy HCFP/AG LLC | 10,000 |
Reported balance
After 2018-04-05 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2018-04-05 · Grant · Acquired 10,000 · Balance 10,000 F1: The reporting person disposed of the Warrants in exchange for Series Z Warrants in an issuer exchange offer. F4: Dr. Aklog is a co-manager of HCFP/AG LLC, and shares joint voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person disposed of the Warrants in exchange for Series Z Warrants in an issuer exchange offer.
F2: Dr. Aklog is a member and a co-manager of HCFP/Capital Partners III LLC, and shares joint voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his proportionate pecuniary interest therein.
F3: Dr. Aklog is a member and sole manager of Pavilion Venture Partners LLC, and has sole voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his proportionate pecuniary interest therein.
F4: Dr. Aklog is a co-manager of HCFP/AG LLC, and shares joint voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 18, 2017 Filed Aug 21, 2017 11:19 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseWarrants · Derivative | 100 | $1.42 Strike: $5.00 | $142.10 |
DisclosureSEC source: 0001094891-17-000209 · edgar.xml · derivative · entry 10 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,600 Underlying: Common Stock · 100 shares Expires 2022-01-29 Read SEC document |
| August 18, 2017 Filed Aug 21, 2017 11:19 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 8,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001094891-17-000209 · edgar.xml · nonDerivative · entry 2 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,877 F2 · price: The shares were purchased at a weighted average price of approximately $3.81 per share. These shares were purchased in multiple transactions at prices ranging from $3.573 to $4.00, inclusive. The reporting person undertakes to provide to PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 11:19 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 1,800 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001094891-17-000209 · edgar.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31.477 F1 · price: The shares were purchased at a weighted average price of approximately $3.43 per share. These shares were purchased in multiple transactions at prices ranging from $3,28 to $3.50, inclusive. The reporting person undertakes to provide to PAVmed Inc., any security holder of PAVmed Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth this footnote to this Form 4. Read SEC document |
| August 16, 2017 Filed Aug 17, 2017 18:21 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 100 | $3.35 | $335.00 |
DisclosureSEC source: 0001094891-17-000205 · edgar.xml · nonDerivative · entry 8 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 300 Read SEC document |
| August 16, 2017 Filed Aug 17, 2017 18:21 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 100 | $3.30 | $330.00 |
DisclosureSEC source: 0001094891-17-000205 · edgar.xml · nonDerivative · entry 7 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 200 Read SEC document |
| August 16, 2017 Filed Aug 17, 2017 18:21 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 100 | $3.20 | $320.00 |
DisclosureSEC source: 0001094891-17-000205 · edgar.xml · nonDerivative · entry 6 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 100 Read SEC document |
| August 16, 2017 Filed Aug 17, 2017 18:21 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 285 | $3.30 | $940.50 |
DisclosureSEC source: 0001094891-17-000205 · edgar.xml · nonDerivative · entry 5 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By daughter Disclosed balance after: 285 Read SEC document |
| August 16, 2017 Filed Aug 17, 2017 18:21 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 300 | $3.32 | $996.00 |
DisclosureSEC source: 0001094891-17-000205 · edgar.xml · nonDerivative · entry 4 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,677 Read SEC document |
| August 16, 2017 Filed Aug 17, 2017 18:21 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 400 | $3.29 | $1,315.60 |
DisclosureSEC source: 0001094891-17-000205 · edgar.xml · nonDerivative · entry 3 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,377 Read SEC document |
| August 16, 2017 Filed Aug 17, 2017 18:21 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 100 | $3.24 | $324.00 |
DisclosureSEC source: 0001094891-17-000205 · edgar.xml · nonDerivative · entry 2 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,977 Read SEC document |
| August 16, 2017 Filed Aug 17, 2017 18:21 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 500 | $3.20 | $1,600.00 |
DisclosureSEC source: 0001094891-17-000205 · edgar.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,877 Read SEC document |
| January 11, 2017 Filed Jan 12, 2017 16:10 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseWarrants · Derivative | 25,000 | $4.00 Strike: $5.00 | $100,000.00 |
DisclosureSEC source: 0001094891-17-000036 · edgar.xml · derivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,500 Underlying: Common Stock · 25,000 shares Expires 2022-01-29 Read SEC document |
| November 29, 2016 Filed Dec 2, 2016 18:06 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 1,777 | $9.02 | $16,035.65 |
DisclosureSEC source: 0001094891-16-000653 · edgar.xml · nonDerivative · entry 2 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,377 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.50 to $10.24, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth this footnote. Read SEC document |
| November 28, 2016 Filed Dec 2, 2016 18:06 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 1,000 | $9.53 | $9,530.00 |
DisclosureSEC source: 0001094891-16-000653 · edgar.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,600 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.50 to $9.80, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth this footnote. Read SEC document |
| November 23, 2016 Filed Nov 28, 2016 20:40 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseWarrants · Derivative | 300 | $8.00 Strike: $5.00 | $2,400.00 |
DisclosureSEC source: 0001094891-16-000651 · edgar.xml · derivative · entry 7 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,550 Underlying: Common Stock · 300 shares Expires 2022-01-29 Read SEC document |
| November 23, 2016 Filed Nov 28, 2016 20:40 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 2,200 | $8.98 | $19,766.78 |
DisclosureSEC source: 0001094891-16-000651 · edgar.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,600 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.71 to $9.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth this footnote. Read SEC document |
| November 21, 2016 Filed Nov 22, 2016 21:07 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 900 | $9.93 | $8,938.98 |
DisclosureSEC source: 0001094891-16-000646 · edgar.xml · nonDerivative · entry 2 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,400 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.20 to $10.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth this footnote. Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 21:07 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 1,400 | $10.07 | $14,096.74 |
DisclosureSEC source: 0001094891-16-000646 · edgar.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.995 to $10.861, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth this footnote. Read SEC document |
| September 16, 2016 Filed Sep 19, 2016 23:12 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 200 | $14.00 | $2,799.60 |
DisclosureSEC source: 0001094891-16-000612 · edgar.xml · nonDerivative · entry 6 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,100 Read SEC document |
| September 16, 2016 Filed Sep 19, 2016 23:12 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 200 | $13.74 | $2,747.00 |
DisclosureSEC source: 0001094891-16-000612 · edgar.xml · nonDerivative · entry 5 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,900 Read SEC document |
| September 16, 2016 Filed Sep 19, 2016 23:12 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 200 | $13.98 | $2,795.96 |
DisclosureSEC source: 0001094891-16-000612 · edgar.xml · nonDerivative · entry 4 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,700 Read SEC document |
| September 16, 2016 Filed Sep 19, 2016 23:12 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 200 | $14.22 | $2,844.90 |
DisclosureSEC source: 0001094891-16-000612 · edgar.xml · nonDerivative · entry 3 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,500 Read SEC document |
| September 16, 2016 Filed Sep 19, 2016 23:12 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 200 | $14.46 | $2,891.30 |
DisclosureSEC source: 0001094891-16-000612 · edgar.xml · nonDerivative · entry 2 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,300 Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 23:12 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 300 | $13.95 | $4,186.14 |
DisclosureSEC source: 0001094891-16-000612 · edgar.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 16:01 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseWarrants · Derivative | 200 | $8.00 Strike: $5.00 | $1,600.00 |
DisclosureSEC source: 0001094891-16-000610 · edgar.xml · derivative · entry 16 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,150 Underlying: Common Stock · 200 shares Expires 2022-01-29 Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 16:01 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 200 | $14.45 | $2,890.00 |
DisclosureSEC source: 0001094891-16-000610 · edgar.xml · nonDerivative · entry 7 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,800 Read SEC document |
| September 13, 2016 Filed Sep 16, 2016 16:01 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseWarrants · Derivative | 300 | $7.00 Strike: $5.00 | $2,100.00 |
DisclosureSEC source: 0001094891-16-000610 · edgar.xml · derivative · entry 15 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,950 Underlying: Common Stock · 300 shares Expires 2022-01-29 Read SEC document |
| September 13, 2016 Filed Sep 16, 2016 16:01 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseWarrants · Derivative | 500 | $6.99 Strike: $5.00 | $3,495.45 |
DisclosureSEC source: 0001094891-16-000610 · edgar.xml · derivative · entry 14 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,650 Underlying: Common Stock · 500 shares Expires 2022-01-29 Read SEC document |
| September 13, 2016 Filed Sep 16, 2016 16:01 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 500 | $12.50 | $6,252.00 |
DisclosureSEC source: 0001094891-16-000610 · edgar.xml · nonDerivative · entry 6 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,600 Read SEC document |
| September 13, 2016 Filed Sep 16, 2016 16:01 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 200 | $12.88 | $2,576.00 |
DisclosureSEC source: 0001094891-16-000610 · edgar.xml · nonDerivative · entry 5 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,100 Read SEC document |
| September 13, 2016 Filed Sep 16, 2016 16:01 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 100 | $12.48 | $1,247.80 |
DisclosureSEC source: 0001094891-16-000610 · edgar.xml · nonDerivative · entry 4 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,900 Read SEC document |
| September 01, 2016 Filed Sep 16, 2016 16:01 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseWarrants · Derivative | 300 | $7.99 Strike: $5.00 | $2,397.60 |
DisclosureSEC source: 0001094891-16-000610 · edgar.xml · derivative · entry 13 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,150 Underlying: Common Stock · 300 shares Expires 2022-01-29 Read SEC document |
| September 01, 2016 Filed Sep 16, 2016 16:01 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 200 | $13.98 | $2,795.50 |
DisclosureSEC source: 0001094891-16-000610 · edgar.xml · nonDerivative · entry 3 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,800 Read SEC document |
| September 01, 2016 Filed Sep 16, 2016 16:01 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 200 | $14.49 | $2,898.00 |
DisclosureSEC source: 0001094891-16-000610 · edgar.xml · nonDerivative · entry 2 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,600 Read SEC document |
| September 01, 2016 Filed Sep 16, 2016 16:01 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 100 | $14.44 | $1,444.00 |
DisclosureSEC source: 0001094891-16-000610 · edgar.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,400 Read SEC document |
| August 23, 2016 Filed Sep 19, 2016 23:12 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseWarrants · Derivative | 100 | $6.35 Strike: $5.00 | $635.00 |
DisclosureSEC source: 0001094891-16-000612 · edgar.xml · derivative · entry 12 Aklog Lishan · CIK 0001665074 · Director · Chairman and CEO · 10% owner HCFP/Capital Partners III LLC · CIK 0001665111 · 10% owner Pavilion Venture Partners LLC · CIK 0001665114 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,250 Underlying: Common Stock · 100 shares Expires 2022-01-29 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.